Theme hub · 110 companies
Neuroscience stocks
Heavily traded in Neuroscience
Turnover over $10M/day26 of about 110 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Oct 30, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| BIIBBiogen Inc. | $226.59M | +68.84% | — |
| NBIXNeurocrine Biosciences, Inc. | $171.27M | +6.06% | Reports Nov 2, 2026 |
| 4523.TEisai Co., Ltd. | $5.80B | +12.79% | Reports Nov 10, 2026 |
| TGTXTG Therapeutics, Inc. | $89.91M | +71.94% | Reports Nov 2, 2026 |
| PRAXPraxis Precision Medicines, Inc. | $125.82M | +47.44% | Reports Nov 9, 2026 |
| ALKSAlkermes plc | $78.12M | +44.26% | Reports Nov 3, 2026 |
| AXSMAxsome Therapeutics, Inc. | $94.91M | +7.59% | Reports Nov 2, 2026 |
| 4506.TSumitomo Pharma Co., Ltd. | $6.18B | +13.39% | Reports Oct 30, 2026 |
BIIB+68.84%$226.59MView analysisNBIX+6.06%$171.27MReports Nov 2, 2026Pre-earnings analysis4523.T+12.79%$5.80BReports Nov 10, 2026Pre-earnings analysisTGTX+71.94%$89.91MReports Nov 2, 2026Pre-earnings analysisPRAX+47.44%$125.82MReports Nov 9, 2026Pre-earnings analysisALKS+44.26%$78.12MReports Nov 3, 2026Pre-earnings analysisAXSM+7.59%$94.91MReports Nov 2, 2026Pre-earnings analysis4506.T+13.39%$6.18BReports Oct 30, 2026Pre-earnings analysisTurnover over $10M/day
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
110 companies, largest market value first.
Data as of Oct 30, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| UNC.DE | UCB SA | $56.26B | Large cap | −16.88% |
| BIIB | Biogen Inc. | $36.90B | Large cap | +68.84% |
| BIIB34.SA | Biogen Inc. | $32.03B | Large cap | +44.45% |
| NBIX | Neurocrine Biosciences, Inc. | $14.88B | Large cap | +6.06% |
| 4523.T | Eisai Co., Ltd. | $8.89B | Mid cap | +12.79% |
| TGTX | TG Therapeutics, Inc. | $8.89B | Mid cap | +71.94% |
| PRAX | Praxis Precision Medicines, Inc. | $7.97B | Mid cap | +47.44% |
| ALKS | Alkermes plc | $7.61B | Mid cap | +44.26% |
| AXSM | Axsome Therapeutics, Inc. | $7.51B | Mid cap | +7.59% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $5.53B | Mid cap | +13.39% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $4.55B | Mid cap | −33.69% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.16B | Mid cap | +39.66% |
| XENE | Xenon Pharmaceuticals Inc. | $3.64B | Mid cap | −11.25% |
| ACAD | Acadia Pharmaceuticals Inc. | $3.48B | Mid cap | −7.86% |
| RGC | Regencell Bioscience Holdings Limited | $3.40B | Mid cap | −58.70% |
| DNLI | Denali Therapeutics Inc. | $3.09B | Mid cap | +18.89% |
| BHVN | Biohaven Ltd. | $2.49B | Mid cap | −8.95% |
| NAMS | NewAmsterdam Pharma Company N.V. | $2.48B | Mid cap | −42.07% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.44B | Mid cap | −24.86% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.25B | Mid cap | +31.62% |
| LBRX | LB Pharmaceuticals Inc | $1.30B | Small cap | +156.55% |
| RAPP | Rapport Therapeutics, Inc. | $1.16B | Small cap | −11.61% |
| SPTX | Seaport Therapeutics, Inc. | $1.09B | Small cap | +6.35% |
| 4547.T | Kissei Pharmaceutical Co., Ltd. | $982.22M | Small cap | −3.23% |
| ANRO | Alto Neuroscience, Inc. | $921.01M | Small cap | +67.17% |
| ALMS | Alumis Inc. | $891.81M | Small cap | +46.28% |
| 4565.T | Nxera Pharma Co., Ltd. | $790.44M | Small cap | +55.03% |
| COLL | Collegium Pharmaceutical, Inc. | $782.31M | Small cap | −30.97% |
| ACHV | Achieve Life Sciences, Inc. | $741.31M | Small cap | +45.25% |
| BHVN34.SA | Biohaven Ltd. | $732.90M | Small cap | +57.78% |
| DRUG | Bright Minds Biosciences Inc. | $559.19M | Small cap | +5.10% |
| DMAC | DiaMedica Therapeutics Inc. | $513.37M | Small cap | +42.30% |
| OVID | Ovid Therapeutics Inc. | $499.96M | Small cap | +76.55% |
| PRTA | Prothena Corporation plc | $455.87M | Small cap | −16.62% |
| MPLT | MapLight Therapeutics, Inc. | $429.04M | Small cap | −53.35% |
| CTNM | Contineum Therapeutics, Inc. | $351.01M | Small cap | −14.40% |
| BIOA | BioAge Labs, Inc. | $272.63M | Small cap | −22.66% |
| ALEC | Alector, Inc. | $250.11M | Small cap | +44.52% |
| VNDA | Vanda Pharmaceuticals Inc. | $244.87M | Small cap | −25.14% |
| ACOG | Alpha Cognition Inc. Common Stock | $200.14M | Small cap | +39.88% |
| ABOS | Acumen Pharmaceuticals, Inc. | $165.63M | Small cap | +1.33% |
| NGEN | NervGen Pharma Corp. | $154.83M | Small cap | −45.66% |
| TLSA | Tiziana Life Sciences Ltd | $120.90M | Small cap | −52.13% |
| AVXL | Anavex Life Sciences Corp. | $120.51M | Small cap | −83.79% |
| ACW.AX | Actinogen Medical Limited | $117.23M | Small cap | +26.47% |
| NRXP | NRx Pharmaceuticals, Inc. | $116.47M | Small cap | −12.79% |
| NERV | Minerva Neurosciences, Inc. | $106.95M | Small cap | −47.04% |
| IMUX | Immunic, Inc. | $106.36M | Small cap | −2.32% |
| HLS.TO | HLS Therapeutics Inc. | $100.84M | Small cap | −15.56% |
| PMN | ProMIS Neurosciences, Inc. | $99.27M | Micro cap | +5.52% |
| COYA | Coya Therapeutics, Inc. | $93.36M | Micro cap | −36.72% |
| TNXP | Tonix Pharmaceuticals Holding Corp. | $92.10M | Micro cap | −71.57% |
| NYR.AX | Nyrada Inc. | $89.20M | Micro cap | −30.50% |
| DICOT.ST | Dicot Pharma AB | $88.31M | Micro cap | −78.74% |
| NTRB | Nutriband Inc. | $80.71M | Micro cap | −4.18% |
| CING | Cingulate Inc. | $75.47M | Micro cap | +45.79% |
| NMRA | Neumora Therapeutics, Inc. | $72.96M | Micro cap | −84.47% |
| CGTX | Cognition Therapeutics, Inc. | $70.31M | Micro cap | −53.20% |
| MNOV | MediciNova, Inc. | $68.91M | Micro cap | +18.64% |
| CLNN | Clene Inc. | $55.43M | Micro cap | −57.33% |
| GANX | Gain Therapeutics, Inc. | $51.94M | Micro cap | −34.62% |
| NUZ.AX | Neurizon Therapeutics Limited | $47.91M | Micro cap | −21.82% |
| LONA | LeonaBio, Inc. | $46.26M | Micro cap | +20.49% |
| INMB | INmune Bio Inc. | $44.41M | Micro cap | −12.09% |
| ANVS | Annovis Bio, Inc. | $43.53M | Micro cap | −53.64% |
| DWTX | Dogwood Therapeutics, Inc. | $41.81M | Micro cap | −80.06% |
| SER | Serina Therapeutics, Inc. | $41.66M | Micro cap | −59.87% |
| ATHE | Alterity Therapeutics Limited | $40.67M | Micro cap | −52.48% |
| ATH.AX | Alterity Therapeutics Limited | $39.98M | Micro cap | −52.73% |
| 4891.T | TMS Co., Ltd. | $39.92M | Micro cap | +2.16% |
| CRVO | CervoMed Inc. | $33.41M | Micro cap | −74.56% |
| FLNA | Filana Therapeutics, Inc. | $31.43M | Micro cap | −80.76% |
| MIRA | MIRA Pharmaceuticals, Inc. | $24.02M | Micro cap | −64.72% |
| IGC | IGC Pharma, Inc. | $20.59M | Micro cap | −50.20% |
| 0R3M.L | Vivoryon Therapeutics N.V. | $20.24M | Micro cap | −42.37% |
| 4586.T | MedRx Co., Ltd | $20.13M | Micro cap | −60.48% |
| NEUP | Neuphoria Therapeutics Inc. | $16.56M | Micro cap | −33.19% |
| QNTM | Quantum BioPharma Ltd. | $15.24M | Micro cap | −81.01% |
| NSB.AX | NeuroScientific Biopharmaceuticals Limited | $14.81M | Micro cap | −47.00% |
| ADIL | Adial Pharmaceuticals, Inc. | $13.26M | Micro cap | −42.29% |
| LPCN | Lipocine Inc. | $12.53M | Micro cap | −43.49% |
| BIVI | BioVie Inc. | $11.98M | Micro cap | −23.33% |
| AGN.AX | Argenica Therapeutics Limited | $9.49M | Micro cap | −62.50% |
| RVPH | Reviva Pharmaceuticals Holdings, Inc. | $9.37M | Micro cap | −95.77% |
| ENSC | Ensysce Biosciences, Inc. | $8.80M | Micro cap | −79.04% |
| VTGN | Vistagen Therapeutics, Inc. | $7.58M | Micro cap | −95.71% |
| ALZN | Alzamend Neuro, Inc. | $5.89M | Micro cap | −50.31% |
| SCNX | Scienture Holdings, Inc. | $5.73M | Micro cap | +282.26% |
| IXC.AX | Invex Therapeutics Ltd | $5.29M | Micro cap | −13.04% |
| ADXN | Addex Therapeutics Ltd | $5.13M | Micro cap | −69.06% |
| NRSN | NeuroSense Therapeutics Ltd. | $4.04M | Micro cap | +100.94% |
| JUNS | Jupiter Neurosciences, Inc. | $3.12M | Micro cap | +65.73% |
| BTAI | BioXcel Therapeutics, Inc. | $2.31M | Micro cap | −97.69% |
| CYCN | Cyclerion Therapeutics, Inc. | $2.25M | Micro cap | +70.56% |
| OGEN | Oragenics, Inc. | $1.62M | Micro cap | −70.99% |
| AB.PA | AB Science S.A. | — | Small cap | −57.20% |
| ADXN.SW | Addex Therapeutics Ltd | — | — | −65.73% |
| AELIS.PA | Aelis Farma SA | — | — | −36.48% |
| ALNFL.PA | NFL Biosciences SA | — | — | −54.98% |
| ALZ.ST | Alzinova AB (publ) | — | Small cap | −71.87% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | — | Small cap | +196.17% |
| BIOA-B.ST | BioArctic AB (publ) | — | Large cap | −2.31% |
| BXT.DE | BioNxt Solutions Inc. | — | — | −59.23% |
| CLN.WA | Celon Pharma S.A. | — | Small cap | −9.91% |
| IDIA.SW | Idorsia Ltd | — | — | +9.48% |
| MEDCL.PA | MedinCell S.A. | — | Small cap | −25.16% |
| MMTX.SW | MindMaze Therapeutics Holding SA | — | — | −86.51% |
| NWRN.SW | Newron Pharmaceuticals S.p.A. | — | — | −43.48% |
| SVNS.L | Solvonis Therapeutics plc | — | — | −70.00% |
| TCF.L | Theracryf Plc | — | — | −14.29% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 110 companies grouped under the Neuroscience theme. The median market value in the group is $106.36M. Among the 71 with a price from the latest session, the median move over the past trading day is 0.00%. 24% of the 107 with a 200-day average trade above it. Price change over the past year runs from −75.0% to +55.3% across the middle 80 percent of the group, with a median of −22.2%.
Other lists in this group
NeuroscienceAdvanced packagingAerospaceAgriculture and agribusinessAI applicationsAI chipsAI datacenter infrastructureAirlinesAlcoholic beveragesAlternative asset managersAluminumApparel and footwearAR VR mixed realityAsset managementAuto partsAutomotive OEMsAutonomous driving softwareBeauty and personal careBiofuelsBitcoin miningBlockchain platformsBrokerage and exchangesBuilding productsCannabisAll stocks
The other 156 themes
Carbon captureCarbon creditsCasual diningCell therapyCell tower REITCement and aggregatesCoal miningCobaltCommercial office REITCommodity chemicalsComputer visionConstruction and engineeringConsumer financeContainers and packagingContract research CDMOCopper miningCredit rating and dataCruise linesCryptocurrency and digital assetsCybersecurityData platformsDatacenter coolingDatacenter powerDatacenter REITDefense electronicsDefense prime contractorsDental careDeveloper toolsDiabetes careDiagnosticsDiamonds and gemstonesDiscount retailDrones and UAVEcommerce marketplacesEcommerce platformsEdge computingEdtechElectrical equipmentEnergy storageEsportsEV batteriesEV chargingEV makersFast food and quick serviceFintech softwareGambling and casinosGaming softwareGene therapyGenerative AIGeneric drugsGeothermalGLP 1 and obesityGold miningGPU cloud computeGraphiteGrocery and supermarketsHealth insuranceHealthcare REITHealthtech softwareHome improvementHomebuildersHospitals and providersHotel REITHotels and hospitalityHousehold productsHR techHVAC and controlsHydroelectricHydrogen economyIndustrial automationIndustrial gasesIndustrial machineryIndustrial REITInsurance brokersInvestment bankingIoT platformsIron oreLife insuranceLife science toolsLithium miningLogistics and 3PLLong term careLumber and forestryLuxury goodsMarine shippingMartech adtechMedical devicesMemory storage semisMissiles and munitionsMoney center banksMortgage financeMortgage REITmRNA platformsNatural gas utilitiesNeobanks and digital banksNickelNon alcoholic beveragesNuclear powerOil and gas explorationOil and gas midstreamOil and gas refiningOil and gas servicesOncologyOnline travelPackaged foodsPayment processingPet carePharmaceuticals large capPotash fertilizerProperty casualty insurancePsychedelic therapeuticsQuantum computingRail transportRare diseaseRare earthsReal estate servicesRegional banksRegulated electric utilitiesReinsuranceRenewable energy developersResidential REITRetail REITRide hailing and deliveryRobotics hardwareSaaSSelf storage REITSemiconductor designSemiconductor equipmentSemiconductor manufacturingShipbuildingSilver miningSocial mediaSolarSpace launch and satellitesSpecialty chemicalsSpecialty financeSpecialty REITSpecialty retailSpeech and audio AISteelStreaming mediaSupply chain softwareSurgical roboticsTelecom equipmentTelecom infrastructureTelemedicineTobacco and nicotineTravel and leisureTrucking and LTLUranium miningVeterinary and animal healthVision and ophthalmologyWaste managementWater utilities and treatmentWealth managementWind